108303-53-3

Basic information

• Product Name: 1,3-Benzodioxole,5-(1-methylethyl)-(9CI)
• Synonyms: 1,3-Benzodioxole,5-(1-methylethyl)-(9CI)
• CAS NO: 108303-53-3
• Molecular Formula: C₁₀H₁₂O₂
• Molecular Weight: 164.20108
• Product Categories: ISOPROPYL
• Mol File: 108303-53-3.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1,3-Benzodioxole,5-(1-methylethyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,3-Benzodioxole,5-(1-methylethyl)-(9CI)(108303-53-3)
• EPA Substance Registry System: 1,3-Benzodioxole,5-(1-methylethyl)-(9CI)(108303-53-3)

Safety Data

• Hazardous Substances Data: 108303-53-3(Hazardous Substances Data)

Usage

Explanation

Isosafrole is an alternative name for 1,3-Benzodioxole,5-(1-methylethyl)-(9CI), which is used to describe the compound more easily.

Explanation

The compound exists in a liquid state at room temperature, and it is both clear and colorless, meaning it does not have any visible color or opacity.

Explanation

Isosafrole has a strong, sharp, and unpleasant smell, which is described as pungent.

Explanation

Isosafrole is used in the production of various products, including fragrances, additives for the food industry, and components in the pharmaceutical industry.

Explanation

Isosafrole serves as a starting material or precursor in the chemical synthesis of MDMA, an illegal psychoactive drug.

Explanation

The International Agency for Research on Cancer (IARC) has classified isosafrole as a potential carcinogen, meaning it has the ability to cause cancer in humans or animals.

Explanation

Due to its potential health and environmental risks, the use of isosafrole is regulated in several countries to minimize exposure and mitigate potential hazards.

Physical state

Clear, colorless liquid

Odor

Pungent

Applications

Perfumes, flavorings, and pharmaceuticals

Precursor

Synthesis of MDMA (ecstasy)

Carcinogenicity

Potential carcinogen (IARC classification)

Regulatory status

Use regulated in many countries

Upstream product

• 119055-67-3 5-(prop-1-en-2-yl)benzo[d][1,3]dioxole 
• 7228-38-8 5-chloro-1,3-benzodioxole 
• 1068-55-9 isopropylmagnesium chloride 
• 3162-29-6 1-(benzo[d][1,3]dioxol-6-yl)ethanone 
• 64-17-5 ethanol 

Downstream Products

• 2138-43-4 4-isopropylcatechol 

Relevant articles and documents

Wagner Meerwein rearrangement of allylbenzene derivatives. I. Bromination of safrole

-

COMPOUNDS AS HSP90 INHIBITORS

The invention provides novel compounds of formula (I) wherein: one of the a, b, c or d members is a nitrogen atom and the remaining members are carbon atoms; and R3 is a radical selected from the group consisting of: —S—R14 and —CH2—R15. The compounds of formula (I) are useful for treating diseases mediated by a heat shock protein 90 (Hsp 90)

2-SACCHARINYLMETHYL PHOSPHATES, PHOSPHONATES AND PHOSPHINATES USEFUL AS PROTEOLYTIC ENZYME INHIBITORS AND COMPOSITIONS AND METHOD OF USE THEREOF

4-R 1-R 2-R 3-2-Saccharinylmethyl and 4,7-C-4,5, 6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates of formulas I and IIA respectively herein, useful in the treatment of degenerative diseases, and compositions containing them, methods for using them to treat degenerative diseases, and processes for their preparation by reaction of the corresponding 2-halomethylsaccharins with a phosphate, phosphonate or phosphinic acid of formula III herein in the presence of an acid-acceptor.